Does young age really put the heart at risk?

Can J Physiol Pharmacol. 2017 Oct;95(10):1177-1182. doi: 10.1139/cjpp-2017-0072. Epub 2017 Jun 19.

Abstract

Despite significant advances in the management and treatment of heart disease in children, there continue to be patients who have worse outcomes than might be expected. A number of risk factors that could be responsible have been identified. Evidence-based findings will be reviewed, including whether young age and (or) reduced body weight exacerbate these responses. For example, newborn children undergoing congenital cardiac surgery are known to have worse outcomes than older children. Evidence exists that newborn hearts do not tolerate ischemia as well as adult hearts, developing irreversible injury sooner and exhibiting at-risk metabolic profiles. As well, in response to the administration of heparin, elevations in free fatty acids occur during congenital heart surgery in children, which can have detrimental effects on the heart. Furthermore, myocardial energetic state has also been suggested to impact outcomes. Unfavourable energetic profiles were correlated to lower body weights in the same age healthy newborn piglet model. Newborn children suffering from congenital heart disease, with lower body weights, also had lower myocardial energetic state and this correlated with longer postoperative ventilatory support as well as a trend to longer intensive care unit stay. These findings imply that unfavourable myocardial metabolic profiles could contribute to postoperative complications.

Keywords: body weight; cœur; energy; heart; intervention chirurgicale; myocardial metabolism; métabolisme myocardique; poids corporel; surgery; énergie.

Publication types

  • Review

MeSH terms

  • Age Factors
  • Animals
  • Antioxidants / metabolism
  • Cardiac Surgical Procedures / adverse effects*
  • Child, Preschool
  • Disease Models, Animal
  • Energy Metabolism*
  • Heart Defects, Congenital / epidemiology
  • Heart Defects, Congenital / metabolism
  • Heart Defects, Congenital / physiopathology
  • Heart Defects, Congenital / surgery*
  • Humans
  • Infant
  • Infant, Newborn
  • Myocardium / metabolism*
  • Oxidative Stress
  • Risk Factors
  • Treatment Outcome

Substances

  • Antioxidants